Protecting Trade Secrets in FDA Submissions from FOIA Disclosure in the Wake of FDA Layoffs

In the wake of recent mass layoffs at the U.S. Food and Drug Administration (“FDA”), the FDA is likely to have fewer resources to manage its regulatory responsibilities. One area that may be significantly impacted by such workforce reduction is the FDA’s review of Freedom of Information Act (“FOIA”) requests....
By: Ropes & Gray LLP

Array